What to know
- CDC has observed an increase in certain Salmonella infections among travelers to or from Mexico.
- The Salmonella causing these infections are a strain of multidrug-resistant Salmonella serotype Newport (MDR Salmonella Newport).
- Information on this page is intended for the management of patients with known or suspected MDR Salmonella Newport infection after travel to or from Mexico.
Diagnosis
- Obtain appropriate cultures (e.g., stool, urine, blood).
- If Salmonella is identified by a culture-independent diagnostic test (CIDT), a follow-up (reflex) culture is recommended to obtain an isolate for antimicrobial susceptibility testing.
- Serologic testing is unreliable and not advised.
- If Salmonella is identified by a culture-independent diagnostic test (CIDT), a follow-up (reflex) culture is recommended to obtain an isolate for antimicrobial susceptibility testing.
- Order antimicrobial susceptibility testing of the Salmonella isolate to guide the choice of antibiotic if antibiotic treatment is needed.
- Laboratory-confirmed salmonellosis infections are reportable in the United States. Follow guidance from your local or state health department.
Patient management
- Limit use of antibiotics for patients with an acute diarrheal illness to those with clinical indications.
- Consider the resistance profile of this strain of MDR Salmonella Newport when selecting empiric treatment for patients who traveled to Mexico in the 7 days before illness began.
- Ceftriaxone or an alternative agent should be considered for empiric treatment.
- Most isolates are susceptible to ceftriaxone.
- Most isolates are resistant to ampicillin, ciprofloxacin, and trimethoprim-sulfamethoxazole.
- Azithromycin may not be effective for treating this strain and should be used with caution. Clinical breakpoints to determine resistance have not been established for azithromycin, but most isolates carry a macrolide resistance gene and show an elevated minimum inhibitory concentration (>32 µg/ml) on laboratory testing.
- Most isolates are susceptible to ceftriaxone.
- Tailor antibiotic treatment to the results of antimicrobial susceptibility testing when possible.
- Consider consulting an infectious disease specialist for management of patients with MDR or complicated Salmonella infection.
- Advise patients about returning to work based on local and state health department recommendations. Some health departments require a negative stool test before a person can return to work in a high-risk setting (such as food preparation, childcare, or healthcare) after a Salmonella infection.
Managing other Salmonella infections
Get in-depth information on managing infections caused by all other Salmonella.
Resources
Antimicrobial-resistant Salmonella
Learn about antimicrobial-resistant Salmonella and ways to access CDC data, including on antibiograms.
Travel guidance
- Travel health notice: A strain of multidrug-resistant Salmonella Newport in Mexico
- CDC Yellow Book
- Travel-related Infectious Diseases: Salmonella
- Preparing International Travelers: Food & Water Precautions
- Travel-related Infectious Diseases: Salmonella
- Travelers' Health Clinician Information Center | CDC
Other
- Clinical practice guidelines for the diagnosis and management of infectious diarrhea | Infectious Diseases Society of America, 2017
- Red Book: Salmonella Infections | American Academy of Pediatrics
- Podcast: Treatment options for Salmonella infection | Consultant 360